Tevogen Bio Holdings Inc. — Form SCHEDULE 13D/A
Filed July 14, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 12/100
What the filing says
Saadi Ryan H. filed an amended Schedule 13D/A for Tevogen Bio Holdings Inc. (market cap ~$63.7M) on July 14, 2026. The filing is an amendment to a prior beneficial ownership disclosure, but the specific changes to ownership percentage, share count, dollar amounts, or the nature of the acquisition are not disclosed in the header/metadata provided. Without the full document text showing the amendments, concrete details cannot be stated.
Why this rating
Amendment to beneficial ownership filing; no material transaction details visible in metadata. Routine disclosure update.
See more from July 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.